Filings a company makes when something has gone wrong, or is about to: a missed reporting deadline (NT 10-K/Q), a delisting from its exchange (Form 25), a deregistration that ends SEC reporting altogether (Form 15), or an insider's notice of intent to sell restricted stock (Form 144). Any one can be routine — Form 144s are filed constantly, and a late filing is sometimes just a late filing — so what is worth reading here is the pattern and the timing.
15,000 shares · $559,800 · via Jefferies LLC · Director
13,000 shares · $606,719 · via Morgan Stanley Smith Barney LLC Executive Financial Services · Director
155 more red-flag filings behind a free account
See every red-flag filing Enliven Therapeutics, Inc. has made, with the filing behind each one.
Sign up freeLoading...
